Common structural polymorphisms in human
erythrocyte spectrin.
W J Knowles, … , S L Marchesi, V T Marchesi
J Clin Invest.
1984;
73(4)
:973-979.
https://doi.org/10.1172/JCI111322
.
Restricted tryptic digestion of erythrocyte spectrin at 4 degrees C followed by
two-dimensional (isoelectric-focusing/sodium dodecyl sulfate) polyacrylamide electrophoresis
yields highly reproducible maps of approximately 50 peptides with molecular weights
between 80,000 and 12,000. Based on molecular weight and isoelectric point (pI), each
unique alpha- and beta-subunit domain can be identified and compared with spectrin
peptides from other individuals. The alpha-subunit of spectrin from 60 Caucasian donors
contains a 46,000-mol-wt tryptic domain, called alpha II-T46, Type 1; more extensive tryptic
digestion of this domain generates peptides with molecular weights of 35,000, 30,000,
25,000, and 16,000. Spectrin from 29 of 37 black donors representing 14 kindreds shows
variation in the molecular weight and/or pI of peptides from the alpha II domain. In the most
common form, Type 2, alpha II tryptic peptides are increased in molecular weight by 4,000,
and the pI becomes more basic. Other alpha II variants are characterized by either the 4,000
increase in molecular weight (Type 3) or by the basic shift in pI (Type 4). When limit peptide
maps of intermediate-sized tryptic and CNBr peptides from the alpha II-domain Types 1 and
2 are compared, a consistent alteration in the chromatographic mobility of one limit peptide
is observed. Polymorphism in the alpha II subunit of spectrin did not itself produce anemia,
nor did it appear to alter […]
Research Article
Common Structural Polymorphisms
in Human
Erythrocyte
Spectrin
W. J. Knowles, M. L. Bologna, J. A.Chasis, S. L. Marchesi, and V. T. Marchesi
Departmentsof Pathology and Internal Medicine, Yale University, New Haven, Connecticut 06510
Abstrtract.
Restricted
tryptic
digestion
of
eryth-rocyte spectrin at
40C
followed by two-dimensional
(iso-electric-focusing/sodium dodecyl
sulfate)
polyacrylamide
electrophoresis yields highly
reproducible maps
ofap-proximately
50
peptides
with molecular weights between
80,000
and
12,000.
Based
on molecularweight
andiso-electric point
(p1),
each
unique
a-and
#-subunit
domain
can
be
identified
and
compared with spectrin
peptides
from other individuals. The a-subunit
ofspectrin
from60
Caucasian
donors
contains
a46,000-mol-wt tryptic
domain,
called
aII-T46, Type 1;
more extensivetryptic
digestion ofthis domain generates peptides
with molecularweights of 35,000, 30,000, 25,000, and 16,000. Spectrin
from 29 of 37 black donors representing
14kindreds
shows
variation
in the molecular
weight and/or
pI of
peptides from the
alldomain.
Inthe
mostcommonform,
Type 2,
all tryptic peptides
areincreased in molecular
weight by 4,000, and the pI becomes
morebasic. Other
all
variants
arecharacterized by
either
the
4,000
increase
in molecular
weight (Type 3)
orby the basic shift in pI
(Type 4). When
limit
peptide
maps of
intermediate-sized
tryptic
and CNBr
peptides
from the all-domain Types
1
and 2 are compared, a
consistent alteration
in the
chro-matographic mobility
of
onelimit
peptide
is observed.
Polymorphism
in the all subunit
of
spectrin
did
notitself produce anemia,
nordid
it
appear
toalter the
expression of
an
underlying hereditary spherocytosis
orelliptocytosis.
Insix
family studies,
the all
46,000-mol-wt
variations observed
wereconsistent
with
Men-delian
inheritance.
Introduction
It isgenerally agreed that spectrin is essential in determining
thepropertiesof the red cellmembrane, includingitsshapeand
Received for publication 7 July 1983 and in revised form 4 November 1983.
deformability. Structuralanalysis ofthespectrinmolecule has been difficult because of the large size of its two nonidentical
subunits, a(240,000mol wt) and
#
(225,000mol wt). In suchalarge and complex molecule, small changes inconformation or physicochemical behaviorwould not necessarilycause
sig-nificant alterations in the properties of the native molecule. Our laboratory has recently developed a technique for analyzing
spectrinstructure; thistechnique useslimited tryptic digestion
of spectrinat0C, followedbytwo-dimensional electrophoresis
(isoelectric-focusing, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis
[IEF/SDS-PAGE]).'
This procedure results in remarkably reproducible maps of approximately 50interme-diate-sizedpeptides whose molecular weights range from 80,000
to 12,000. These peptides may be enzymatically digested or
chemicallycleaved and the resultant limit peptide analyzed by high-resolution mapping techniques. With these procedures, it is possible to assign the origins of all peptides to thea- or
lB-subunit,todetermine relationships between peptides at various stages ofdigestion,and to arrange the unique peptides linearly,
producingadomain structure for each spectrin subunit (1). These techniques have been applied to the study of red cell membranes of patients with hereditary spherocytosis (HS) and hereditary elliptocytosis (HE) and their variants. We and others (2, 3) have recently demonstrated that patients with severe
poi-kilocytichemolyticanemia(hereditarypyropoikilocytosis, HPP) have abnormalities in the80,000-mol-wtdomain of the a-chain.
Inthis study, we describe the occurrence of polymorphisms in the all domain that involve changes in both the molecular weight and the isoelectric point (pI). Thesepolymorphismshave beenfound only in the blackpopulation,arerelatively common, and appearnot to becorrelated with any clinicalabnormality. The first family in which we demonstrated an all poly-morphism was a black family withclassical HS. Heterozygous and homozygous forms of the alI variant were detected and they occurred inpredictableMendelianfashion,butsegregated
independently ofspherocytosis. We subsequently studied 37
blackindividuals from 14kindredsand we discovered a poly-morphicall domain in 29 of theseindividuals, the variations beinginmolecularweightorpIorboth,seeninsingleordouble
1. Abbreviations used inthispaper:DFP, diisopropyl fluorophosphate; HE, hereditary elliptocytosis; HPP, hereditary pyropoikilocytosis; HS, hereditary spherocytosis; IEF/SDS-PAGE, isoelectric-focusing,
SDS-polyacrylamide gel electrophoresis.
973 Spectrin:Common StructuralPolymorphisms J.Clin.Invest.
©TheAmericanSociety for ClinicalInvestigation, Inc. 0021-9738/84/04/0973/07 $ 1.00
13 IV
D4 IV
sCjY
-80
i(~
13 11-,
3
o
I-( 111
-
(§~3I1
1
APO
heterozygote form.Wemadenoattempttodetermine theactual
frequency of these variantsin the blackpopulation.
Methods
Spectrin preparation
Blood was drawn into acid citrate dextrose anticoagulantand storedat 4VC until processed,no morethan 24 h.Erythrocytemembraneswere prepared and spectrinwasextractedaspreviouslydescribed (4). Tryptic digestion of spectrin
200-,ugaliquots of spectrin in 200MAlweredialyzed against 20mM Tris-HCI, pH 8.0, 1 mM2-mercaptoethanol for 20hat4VC.Trypsin
(N-tosyl-L-phenylalaninechloromethyl ketone-treated, 206
Am/mg;
Wor-thington Biochemical Corp., Freehold NJ) was addedatan enzyme/
substrate ratio of 1:20 (wt/wt). The reaction was carried out at4VCfor
lT 46 l
T35 T30
T235
m
m2I T41 -i
T$ T3
T6OS 1i 33 1,
Figure 2. Diagrammaticrepresentation of thea-and,8-chainsof
spectrindeducedfromchemicaland enzymaticcleavageand
map-pingofoverlap peptides (8-10). Numbersindicatemolecular weight inthousands.
Figure
1.Electrophoresis
ofspectrin peptide gen-eratedby
limitedtryptic digestion
at4VC. (A)75-52
fig
Iyophilizedtryptic digestin 2%SDS,2% 1--46 mercaptoethanol electrophoresedona10-15%ac-rylamide gradient according
toLaemmli(5). (B)
-35
200 Migtryptic digest
electrophoresedintwodi--30
mensions (IEF/SDS) according to O'Farrell (6). ThepHgradient (horizontal) extends from 7.2to4.5
(left
toright);
theacrylamide gradient(verti-cal)is from 10to 15%. Uniquedomains in the
a-and E-chainsarecircled. Lower molecular
weight
trypticdigestion
productsof theaII-T46domain -17 areconnected by lines from the parent domain.Numbers indicate molecularweightin thousands.
90 minandterminated
by
adding diisopropyl fluorophosphateto afinal concentration of 1 mM andcoolingto-80'C. Thetryptic digestswerelyophilized
andstoredat-20'C for furtheruse.-80K
-~~~
-- rn
-
--USUP3U-46 K
_ =
~~=Z n"
woo*.
...0
..ow*
,
1/
2, 2,
i, 1,
112
2
1
2
Figure3.Type2variation inthe aII-T46domain of spectrin. Inter-mediatetrypticpeptides of spectrin (75,ug)from members ofa
fam-ilywith all Type 2 polymorphismareelectrophoresedon a10-15%
acrylamide gradient bySDS-PAGE. 1/1:spectrinhomozygous foraII
Type 1.2/2:spectrin homozygous foraIIType2. 1/2:spectrin
dou-bly heterozygous forall Types 1and 2.39 K, 39,000-mol-wt pep-tide;46K,46,000-mol-wt peptide;80K, 80,000-mol-wtpeptide.
A
-B
Em
I
U
UP
NI
A
I
B
I
T7 28Tl
P
SI
_
Polyacrylamide
gel
electrophoresis
One-dimensional electrophoresis. 75 sgofspectrin tryptic peptides pre-paredasdescribed above wassolubilizedin 2% SDS, 2%
2-mercapto-ethanol andelectrophoresed accordingto Laemmli (5) on acrylamide
gradients,asspecified in Figurelegends.
Two-dimensionalelectrophoresis (IEF/SDS-PAGE). 200 ug of
ly-ophilized spectrin tryptic digests wassolubilizedin 75
Al
9 M urea, 2% Triton X-100, 5%2-mercaptoethanol,and 2.4%ampholines,and focused on3 X 120 mmpolyacrylamide gelsaccordingto O'Farrell (6). The pH gradient extended from 7.2 to 4.5 and was formed by mixing equal volumes ofampholytes(LKBInstruments, Inc.,RockvilleMD) at pH 4-6, pH 5-7, and pH 3.5-10 (2.4% finalampholyte concentration). Afterelectrophoresisfor 5,700 V/h, the gels were removed andequil-ibrated for 10 min in 10% glycerol, 3% SDS, 1 mM EDTA, and 2%
2-mercaptoethanol beforeelectrophoresisin the seconddimension ona 10-15%acrylamidegradient using Laemmli buffers (5).Molecularweights weredetermined byreferenceto known protein standards.
CNBr
cleavage
Lyophilized spectrin (1 mg) was dissolved in 70% formic acid. A 500-fold molar excess of CNBr (Pierce Chemical Co.,Rockford, IL) with
respecttomethioninewas added and the reaction was allowed to proceed
overnight at 37°C. The reaction was terminated by drying with N2,
followed by repeated resuspension in water andlyophilization.The sam-ples were then subjected totwo-dimensional electrophoresisaccording toO'Farrell (6) asdescribedabove.
1/1
---.
.
"W
_0I
--wr.
El
_
.
2
1 _
2/2
-*&
a-A
_w-e
2_
0
ob
~~
: 4w 4 _kW212
Figure
4.Two-dimensional IEF/SDS-PAGE
showing
homozy-gousand
heterozygous
Type
2polymorphism
in the aII do-main. The parent domains(all-T46 and
aII-T50,
Type 2),
arecircled and connectedbylinesto
thesubdomains
aII-T35
andaII-T39
(Type
2), respectively. Gel conditionsare asinFig. IB;
alltypesaredesignated
asinFig.
3.2SI-peptide mapping
Two-dimensional
peptide
mapswerepreparedby
the method of Elderetal.
(7) using
CoomassieBlue-stainedproteins
cutfromacrylamide
gels
and labeled withNa'25I (New England Nuclear, Boston, MA)
aspreviously
described(8, 9). lodinated gel
slicesweredigested
with 50 Mgofa-chymotrypsin (Worthington
BiochemicalCorp.)in 1 ml of 50 mM ammoniumbicarbonate,
pH 8.0,for 24 hat37°C. Thelyophilized
samplesweresubjected
totwo-dimensionalpeptide mapping;
details of thisprocedurehave been described earlier(8, 9).
Results
Two-dimensional
electrophoresis
of
intermediate-sized
tryptic
peptides
of
spectrin.
We haveisolatedspectrin
fromthe red cells of 97individuals and from 10 cordbloodsamples,
cleaved itby
limitedtryptic
digestion
at0°C,
andanalyzed
the resultantintermediate-sized
peptides
by
one-andtwo-dimensional
elec-trophoresis.
Thepeptide
patterns obtained arehighly
repro-ducible,
and bloodgiven
by
asingle
donoronmultiple
occasions hasalways
produced
thesamespectrin peptide
patterns, whethernormal orabnormal. A
typical
spectrin
digest
canbeseen onone-dimensional SDS-PAGEin
Fig.
1A andontwo-dimensionalIEF/SDS-PAGE
inFig.
I B. ItisapparentfromFig.
1 that thecomplexity
ofthespectrin
digest
requires
two-dimensionalelec-trophoresis
to resolve allspectrin
domains andsubdomains,
975
Spectrin:
Common StructuralPolymorphisms
1/2
0
i_
2_
_50K
M
_
346K
-39K
I
M~3
"5K
and it is this techniquethat we have used toanalyzethe structure
ofthespectrin molecule. Inearlier work inourlaboratorythat
combined two-dimensional electrophoresis and peptide
map-ping, we identified the origin andrelationships ofthe majority oftryptic peptides separated on two-dimensional gels (8-10). The unique a- and (3-chain domains are identified in Fig. 1 B andindiagrammatic form inFig. 2.
In analyzing spectrin from normal volunteers and from
families with HS, HE, and HPP,we have detecteda polymor-phism within the alldomain.The common alltrypticdomain
ofspectrin from 60 Caucasian donorshas amolecular weight of46,000 (aII-T46) and is called Type 1(Fig. 1 B). This peptide has two prs,possiblyowingtovariabledeamidation,whichare
identical by peptidemapping(datanotshown). Trypticdigestion
at 00C produces a subfragment ofall that has a molecular
weight of 35,000; peptides with molecular weights of 30,000, 25,000, and 16,000canbeproducedbymoreextensive tryptic digestion. Peptide maps (Fig. 5) have confirmed that the lower
molecularweight peptidesarefragmentsof the 46,000-mol-wt
domain,and amonoclonalantibodyhas been made whichreacts
with a determinant common to all but the 16,000-mol-wt frag-ment(10).
The all domain ofspectrin from 29 of 37 black donors
studied shows alterationsinmolecularweight and/orpI.These
variations occur in what appear to be heterozygous and ho-mozygous forms. In the most common form ofthe variant, Type 2, theaII-T46 domain and the aII-T35 subdomain increase in apparent molecular weight by 4,000 and become slightly more basic. The all Type2 polymorphism can beseen on a
one-dimensional gel(Fig.3) by the loss ofa46,000-mol-wtband in homozygotes and the presence ofa 39,000-mol-wt band. Two-dimensional maps arerequired, however, for adequate
res-olution andanalysisofindividualpeptidesin thisregion(Fig. 4). Thedifference in pI and molecularweightismost noticeable
in the heterozygous condition 1/2,where both the normal and variant peptides are found(Fig. 4,sections labeled 1/2).
Otherdifferences among the all Types 1/1, 1/2, and 2/2 appear on the one-dimensional gels in the 70,000-90,000 region.
Two-dimensionalgelsfrom normal controls show some degree ofvariabilityin this group ofpeptides, whichareknownfrom
limitpeptide mapping to represent several different domains. Using one monoclonal antibody to one aII-T46 domain (see
reference 10), wedetected no allpeptidesin this groupof pep-tides.
Limit peptide maps of variant aIItryptic domains. Limit chymotryptic maps of the Type 1 and Type2 all domains are shown inFig.5.Maps ofthe 46,000-mol-wt (Type 1) and 50,000-mol-wt (Type 2) peptides (Fig. 5, A and B), and of 35,000-mol-wt (Type 1) and 39,000-35,000-mol-wt (Type 2) peptides (Fig. 5, C and D) showadifferencein a singleiodinatablepeptide, the Type 2 variant having a relative decrease in mobility in the
chromatographic dimension. Sincethese maps show only
io-dinatable peptides, predominantlythose that contain tyrosine, and onthe average only 33% of allpeptides contain tyrosine,
otherpeptides may also be altered but remain undetected by this procedure.
A
!
C
B
f
*
p.'
;
it,1
S
:
VW
D
.9
6.P
9
E
'V0
V
>_4 0
:1:-h
4
a: 2
0
cc (.
F
* l
ELECTROPHORESIS
Figure5.Autoradiographs of limit chymotryptic mapsof iodinated intermediate tryptic peptides of the all domain: comparison of maps from all Type 1 and Type 2. A, C,E areall Type 1:46,000, 35,000,
16,000 molwt, respectively. B, D, F areall Type 2: 50,000, 39,000, 20,000 molwt, respectively. The small arrowsineach map denote thepeptide withachangein mobility in the chromatographic dimen-sion.
The subfragments ofthe aII domain withmolecularweights <35,000are notnormally produced bythe mildtryptic digestion procedure used in these experiments. Type 1 aII-T30,aII-T25,
Variant aII domains are also produced by CNBr cleavage. Since the allpeptidesdiscussed above were generated by tryptic digestion, it seemedpossiblethat a lysine or arginine normally present on one end ofthe all domain was either buried or substituted in the Type 2 variant.Trypticdigestion would then havecleaved the next lysine or arginine, possibly producing a slightly larger (50,000-mol-wt) domain. To characterize further the variant all domains, spectrin homozygous for Type 1 or Type 2 was cleaved with CNBr in 70% formic acid. All peptides that resulted from the cleavage wereidenticalwith oneexception:
Type 1 spectrin contained a 23,000-mol-wt peptide that was slightly more acidic than a corresponding 26,000-mol-wt peptide in Type 2spectrin. Limitchymotrypticpeptide maps of these CNBrpeptides showed that both 23,000-mol-wt and 26,000-mol-wtpeptides are derived from the all domain and that they
differin themobilityof onechymotryptic peptidein the same manner as the maps of the 46,000-mol-wt (Type 1) and 50,000-mol-wt(Type 2) tryptic peptides (Fig. 6, A and B). The prelim-inary interpretation of thesefindingsis that the all variants are produced not simply by burial or substitution of a single lysine
or arginine, but that the polypeptide chain in this region is increased in apparent molecular weight byapproximately4,000.
Family studies ofspectrin aII variants. The initial family
in which we detected theallType 2 variation was a black family with classical HS (Fig. 7). A father and three of the five children tested hadclassical HS: the three affected brothers had sphe-rocytes on smear, abnormal osmotic fragility tests, and hema-tocrits of 34-36% with elevated reticulocyte counts. Two of the sons and the father had had their spleens removed. The two
unaffecteddaughters had normalosmoticfragilitytestsand one had ahematocrit of 40% in 1976 at age 23. When studied in 1981, both daughters had mild anemia with hematocrits 36-37%. Red cell indices,peripheralsmears,ferritin,andtransferrin
levels suggested mild iron deficiency.
When we examined the tryptic digest of spectrin from this
familybytwo-dimensional IEF/SDS-PAGE, wenotedaII-T46
Type 2 in either the heterozygous or homozygous form in five
ofsevenfamily members(Figs. 4 and 7). Thedistribution of
A
aII-T46 Type 2 followed classical Mendelian genetics but did notcorrelate with the presence of spherocytosis. The two child-ren who were homozygous for the aII-T46 variant did not have HS.
Wesubsequently demonstrated other structural variations within the all domain of black donors. In the Type 3 variation, only the molecular weight ofthe domain changes (increasing
by 4,000), and the pI remains the same. Type4 consists of a pI change only, thedomainbecomingslightlymore basic. Fig.
8 shows the spectrin maps of donors whose spectrin has both
all Types 1 and 3 (1/3), Types 3 and 4 (3/4), and Types 2 and4 (2/4). The bottom right panelofFig. 8 is a composite
drawingofthe relative positions of peptides in all variants 1 through 4.
Note that the twotypes of all peptides found in one in-dividual are not always present in equalquantities(e.g.,Fig.8, 1/3), which one would expect if the donor wereatrue hetero-zygote. This may be due to different susceptibilities ofeach variant to tryptic digestion or may suggest that there are more than two alleles for eachspectrin subunitin the genome.Athough family studieswereincomplete,the all variants observedwere
consistentwithsimple Mendelian
genetics
insix familiesstudied.The distribution ofvariant
spectrins
seen in the 37 black individuals (14kindreds) studiedis indicated below:Type-No. Type-No. Type-No. Type-No.
1/1-8
1/2-17
1/3-1
1/4-3
2/2-3
2/3-3
2/4-1
3/3-0
4/4-03/4-1
Thepolymorphic spectrins were discovered duringastudy of
patients with HS, HE, and relateddisorders;threeofthe black
familiesstudiedhaveHS,one hasHE, and three have HE and HPP,representing 27 of the 37 blackindividuals. The presence of theaIIvariant didnotappeartoaffecttheclinical
presentation
of these disorders.B
4,
i.o
ELECTROPHORESIS o
Figure6.Autoradiographsof limit chymo-trypticmapsof iodinated CNBrcleavage products. (A) aIl Type 1, 23,O00-mol-wt peptide. (B) aII Type 2, 26,000-mol-wt peptide.Arrows denotepeptidewith
changein mobilityinthechromatographic
dimension.
977 Spectrin:Common StructuralPolymorphisms
I
oit
0.
0
I-a
0
C:)
ocCIType 0
Figure
7.Genealogy
offamily
with2 ~~~classical HS and allType2
polymor-I/2
phism.
Discussion
The searchforstructural abnormalitiesin alargemoleculesuch asspectrin requiresamethod that notonly surveystheentire molecule but that is sensitive enoughtopick upsmallchanges
in molecular weights or pI within a domain. The analysis of intermediatetryptic peptides of nativespectrin by two-dimen-sionalelectrophoresisdescribed above appearsto be onemethod
suitableforthistask. Furthermore, it iscompatible withsmall volumes of bloodobtainablefrompatients (including children)
with hemolyticanemias.Thepeptidesarewell resolved and the maps arehighly reproducible.
Innormalspectrin,mostof thelysineandarginine residues
areprotected fromtryptic digestion bythe nativeconformation ofthemolecule. Smallchangesin sequence, abnormal subunit
association, or oxidative damage could change conformation enough to expose or bury an arginine or lysine residue and
thereby result in altered trypticdigestion of native spectrin.For example, inspectrin obtained from patients withHPP, an ab-normalconformationwithin the aI-T80domaincauses a new
trypticcleavagewhichgenerates twopeptidesnotobtained from
normalspectrin (2).
The allvariants illustratedabove demonstrate well the sen-sitivityofthismethod to small structural changes inspectrin.
In contrast to the findings in HPPspectrin, however (2), the allvariants are not the resultofnewtrypticcleavages. Theall
polymorphismsdescribedhereconsist oftwodistinct structural
changes, a molecular weight increase, as in Type 3, andabasic shift in pI, as in Type 4. The Type 2 all variant, which has both the molecular weight and pI change, appears to be the result of two changes within a singledomain.Thelimitpeptide
maps and the cyanogenbromide digests from allType 2spectrin
suggest that thealterations are notthe resultof burialor sub-stitution ofalysineorarginine residue,butaredue,atleast in part, to asequence alteration that increases itsapparent mo-lecular weight by 4,000. This apparent increase in momo-lecular weight may be the result of a 4,000-mol-wt insert (roughly 35 aminoacids) possibly occurringatanexon-intron interfaceor
atan mRNAsplice junction. Alternatively, specific amino acid substitutionshave been showntoincreasethe apparentmolecular
weight of a protein by 2,000 (11). The change in pI may occur
at adifferentsite within thepolypeptide chain,butit ispresent in the firstmajorcleavage product
(all
T35).*
(9
4 _ ,
0
2/4
...
WCr
__
4-j2
. ,4 _
2 3
481
4 1
__d
2 3
C21O CubP
4 1 0
Figure 8. Two-dimensionalIEF/SDS-PAGEof
spec-trin fromindividualsdoubly heterozygousfor all
variants 1, 2, 3, and 4. A schematic representation
of therelativepositions of Types 1, 2, 3,and 4
pep-tides is shown in the lowerright panel;solidareas areforreferencetootherspectrin peptidesseen on
two-dimensionalelectrophoresis.
1/3
aII Type 2 spectrin occurred most frequently in theblack
population we studied, the sample size was small, and two kindredsthat accountedfor14ofthe 37 blackindividualsstudied werepredominantly 1/2 variants; therefore, no conclusionscan
be drawn from this study about frequency of spectrin all vari-ation in the black population, nor about the most common type of variation.
Weobserved no change in behavior of the red cell caused byall polymorphism, at least by clinical criteria. This is in
contrast toalterations in the aI-T80 domain that are associated with HPP and HE (2, 3 and Knowles, W. J., J. S. Morrow,
S. L.Marchesi, and V. T. Marchesi, manuscript in preparation). Although manyof our HS, HE, and HPP patients have poly-morphic all domains, we do not yet have enough data to de-termine whether this subtly influences the occurrenceor
expres-sionof thesehereditaryhemolytic anemias.Thequestionarises
astowhetherpolymorphism suchasthat seen in the all domain and a structural changecausinghemolyticanemiamust occur
onthe samepolypeptide chain foramplificationof the potential forhemolysis. Alternatively,doesapolymorphismonone
sub-unit increase the hemolytic potential of a structural changeon
the othersubunit? These questions will be answered by con-tinuingphenotypic andgenotypicanalysisofspectrinand other structuralproteins of the red cell membrane.
Acknowledaments
Theauthorswouldliketoacknowledge Dr.David Speicherfor hishelp in analyzingthepeptidemaps. We alsoacknowledge theassistanceof Drs.JosephBove,David Seligson,and PeterMcPhedran incollecting blood samples and inperformingclinical laboratorytests.
Thiswork wasfundedbyU.S.PublicHealthServicegrantAM27932.
References
1. Marchesi, V. T. 1983. The red cell membrane skeleton: recent
progress. Blood. 61: 1-11.
2.Knowles,W.J.,J.S.Morrow,D. W.Speicher,H.S.Zarkowsky,
N.Mohandas,W.C. Mentzer, S. B. Shohet, andV. T.Marchesi.1983. Molecular and functional changesinspectrin from patientswith
he-reditarypyropoikilocytosis. J. Clin. Invest. 71:1867-1877.
3. Lawler, J., S.-C. Liu, J. Palek, and J. Prchal. 1982. Molecular defect ofspectrin in hereditary pyropoikilocytosis: alterations in the trypsin-resistant domain involvedinspectrin self-association. J. Clin. Invest. 70:1019-1030.
4. Litman, D.,C. J.Hsu,andV. T. Marchesi. 1980.Evidencethat spectrin bindsto macromolecular complexes on the innersurface of thered cell membrane.J Cell Sci. 42:1-21.
5.Laemmli,U. K. 1970.Cleavageof structuralproteins duringthe assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
6.O'Farrell,P.1975.High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250:4007-4021.
7.Elder,J.H.,R. A.Pickett,J.Hampton,and R. A.Lerner. 1977. Radio-iodination ofproteininsinglepolyacrylamidegelslices. J. Biol. Chem. 252:6510-6516.
8.Speicher,D.W.,J. S.Morrow, W. J. Knowles, and V. T.Marchesi. 1980.Identificationofproteolytically resistant domains ofhuman eryth-rocyte spectrin. Proc. Natl. Acad. Sci. USA. 77:5673-5677.
9.Speicher, D. W., J. S. Morrow, W. J.Knowles,and V. T. Marchesi. 1982. Astructural modelofhumanerythrocytespectrin:alignment of chemical and functional domains. J. Biol. Chem. 257:9093-9101.
10. Yurchenco, P. D.,D.W.Speicher,J.S. Morrow, W. J. Knowles, andV. T.Marchesi. 1982. Monoclonal antibodiesasprobes of domain structure of thespectrin subunit. J. Biol. Chem. 257:9102-9107.
11.Noel, D.,K.Nikaido,andG. Ames. 1979.Asingle aminoacid substitution inahistidine-transport protein drasticallyalters its mobility insodiumdodecylsulfate-polyacrylamidegelelectrophoresis. Biochem-istry. 18:4159-4165.